Jiangsu Apon Medical Technology Co., Ltd.

Total Valuation

Jiangsu Apon Medical Technology Co., Ltd. carries a market capitalization of 2.58B, placing it among publicly traded companies globally. Its enterprise value stands at 4.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Jiangsu Apon Medical Technology Co., Ltd. currently has 126.05M shares outstanding.

Valuation Ratios

Jiangsu Apon Medical Technology Co., Ltd. trades at a trailing price-to-earnings ratio of 134.15. The price-to-sales ratio is 10.84, and the price-to-book ratio stands at 14.41.

Enterprise Valuation

On an enterprise value basis, Jiangsu Apon Medical Technology Co., Ltd. trades at an EV/EBITDA multiple of 375.97 and an EV/FCF ratio of 326.71. The EV/Sales ratio of 10.71 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 375.97 provides insight into valuation relative to core operating earnings.

Financial Position

Jiangsu Apon Medical Technology Co., Ltd. maintains a current ratio of 3.47, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.03, indicating elevated leverage, while an interest coverage ratio of -0.64 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Jiangsu Apon Medical Technology Co., Ltd. has paid -694,989.61 in income taxes, reflecting an effective tax rate of 34.17.

Stock Price Statistics

Jiangsu Apon Medical Technology Co., Ltd.'s stock has declined approximately -36.1881% over the past 52 weeks. The 50-day moving average sits at 23.78, while the 200-day moving average is 28.80.

Income Statement

Over the trailing twelve months, Jiangsu Apon Medical Technology Co., Ltd. generated 383.50M in revenue and converted that into -17.47M in net income, yielding earnings per share of -0.14. EBITDA reached -2.02M, while operating income came in at -2.02M.

Balance Sheet

Jiangsu Apon Medical Technology Co., Ltd. holds 169.87M in cash and equivalents against 109.15M in total debt, resulting in a net debt position of -80.07M. Total book value stands at 288.51M, with working capital of 305.60M providing operational flexibility.

Cash Flow

After subtracting -9.54M in capital expenditures, free cash flow totaled -9.54M - equivalent to -0.08 per share.

Margins

Jiangsu Apon Medical Technology Co., Ltd. operates with a gross margin of 66.37, reflecting its pricing power and cost economics. The operating margin of -0.53 and net profit margin of -4.56 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -54.36 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Jiangsu Apon Medical Technology Co., Ltd.'s most recent stock split took place on June 2, 2021 with a 5:6 split ratio.

Scores

Jiangsu Apon Medical Technology Co., Ltd. posts an Altman Z-Score of 17.76, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.